(c) 2024 PillSync.com

lisdexamfetamine dimesylate 60 mg

1 INDICATIONS AND USAGE Lisdexamfetamine dimesylate capsules are indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see Clinical Studies ( 14.1 )] Moderate to severe binge eating disorder (BED) in adults [see Clinical Studies ( 14.2 )] . Limitations of Use : Pediatric patients with ADHD younger than 6 years of age experienced more long-term weight loss than patients 6 years and older [see Use in Specific Populations ( 8.4 )] . Lisdexamfetamine dimesylate capsules are not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of lisdexamfetamine dimesylate capsules for the treatment of obesity have not been established [see Warnings and Precautions ( 5.2 )] . Lisdexamfetamine dimesylate capsules are a central nervous system (CNS) stimulant indicated for the treatment of ( 1 ): Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older Moderate to severe binge eating disorder (BED) in adults Limitations of Use : Pediatric patients with ADHD younger than 6 years of age experienced more long-term weight loss than patients 6 years and older. ( 8.4 ) Lisdexamfetamine dimesylate capsules are not indicated for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of lisdexamfetamine dimesylate capsules for the treatment of obesity have not been established. ( 5.2 )

specgx llc


1 year ago CAPSULE BLUE M 5116 60mg lisdexamfetamine dimesylate 60 mg

CAPSULE BLUE M 5116 60mg

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

LISDEXAMFETAMINE DIMESYLATE capsules:

LISDEXAMFETAMINE DIMESYLATE capsules 10 mg: Opaque pink Cap/Opaque pink Body, Hard Gelatin capsules, imprinted with black ink “10 mg†on the body and “M†in a box over “5111†on the cap Bottles of 100.................................................. NDC 0406-5111-01

LISDEXAMFETAMINE DIMESYLATE capsules 20 mg: Opaque yellow Cap/Opaque yellow Body, Hard Gelatin capsules, imprinted with black ink “20 mg†on the body and “M†in a box over “5112†on the cap Bottles of 100.................................................. NDC 0406-5112-01

LISDEXAMFETAMINE DIMESYLATE capsules 30 mg: Opaque orange Cap/Opaque white Body, Hard Gelatin capsules, imprinted with black ink “30 mg†on the body and “M†in a box over “5113†on the cap Bottles of 100.................................................. NDC 0406-5113-01

LISDEXAMFETAMINE DIMESYLATE capsules 40 mg: Opaque green Cap/Opaque white Body, Hard Gelatin capsules, imprinted with black ink “40 mg†on the body and “M†in a box over “5114†on the cap Bottles of 100.................................................. NDC 0406-5114-01

LISDEXAMFETAMINE DIMESYLATE capsules 50 mg: Opaque blue Cap/Opaque white Body, Hard Gelatin capsules, imprinted with black ink “50 mg†on the body and “M†in a box over “5115†on the cap Bottles of 100.................................................. NDC 0406-5115-01

LISDEXAMFETAMINE DIMESYLATE capsules 60 mg: Opaque blue Cap/Opaque blue Body, Hard Gelatin capsules, imprinted with black ink “60 mg†on the body and “M†in a box over “5116†on the cap Bottles of 100.................................................. NDC 0406-5116-01

LISDEXAMFETAMINE DIMESYLATE capsules 70 mg: Opaque orange Cap/Opaque blue Body, Hard Gelatin capsules, imprinted with black ink “70 mg†on the body and “M†in a box over “5117†on the cap Bottles of 100.................................................. NDC 0406-5117-01 16.2 Storage and Handling Dispense in a tight, light-resistant container as defined in the USP. Store at room temperature, 20° to 25°C (68° to 77°F). Excursions permitted between 15° and 30°C (59° to 86°F) [see USP Controlled Room Temperature] .


More pills like CAPSULE M 5116 60mg












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site